Peter Warn

8.1k total citations · 2 hit papers
74 papers, 5.3k citations indexed

About

Peter Warn is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Peter Warn has authored 74 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Infectious Diseases, 38 papers in Epidemiology and 18 papers in Pharmacology. Recurrent topics in Peter Warn's work include Antifungal resistance and susceptibility (44 papers), Fungal Infections and Studies (31 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). Peter Warn is often cited by papers focused on Antifungal resistance and susceptibility (44 papers), Fungal Infections and Studies (31 papers) and Antibiotics Pharmacokinetics and Efficacy (12 papers). Peter Warn collaborates with scholars based in United Kingdom, United States and Kenya. Peter Warn's co-authors include David W. Denning, Robert W. Snow, Paul Bowyer, Norbert Peshu, Alessandro C. Pasqualotto, Mohammad Taghi Hedayati, Kevin Marsh, Joanne Sharp, Charles R. Newton and Geoffrey Pasvol and has published in prestigious journals such as Nature, New England Journal of Medicine and PLoS ONE.

In The Last Decade

Peter Warn

74 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Indicators of Life-Threatening Malaria in African Children

1995 798 citations Kevin Marsh, Charles R. Newton et al. profile →
Aspergillus flavus: human pathogen, allergen and mycotoxin producer

2007 703 citations Mohammad Taghi Hedayati, Alessandro C. Pasqualotto et al. Microbiology profile →

Peers

Countries citing papers authored by Peter Warn

Since Specialization

Citations

This map shows the geographic impact of Peter Warn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Warn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Warn more than expected).

Fields of papers citing papers by Peter Warn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Warn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Warn. The network helps show where Peter Warn may publish in the future.

Co-authorship network of co-authors of Peter Warn

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Warn. A scholar is included among the top collaborators of Peter Warn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Warn. Peter Warn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetic/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea—challenges and opportunities 2020 ·Clinical Microbiology and Infection ·Ursula Theuretzbacher, Lindley A. Barbee, Kristie L. Connolly, George L. Drusano, (unknown), Edward W. Hook, Ann E. Jerse, John P. O’Donnell, Magnus Unemo, Françoise Van Bambeke, Brian VanScoy, Peter Warn, Brian J. Werth, F. Franceschi, Emilie Alirol	15
2	Infection Augments Expression of Mechanosensing Piezo1 Channels in Amyloid Plaque-Reactive Astrocytes 2018 ·Frontiers in Aging Neuroscience ·María Velasco‐Estevez, Myrthe Mampay, Hervé Boutin, Aisling M. Chaney, Peter Warn, Andrew A. Sharp, (unknown), Emad Moeendarbary, Kumlesh K. Dev, Graham K. Sheridan	69
3	Azole Resistance of Aspergillus fumigatus Biofilms Is Partly Associated with Efflux Pump Activity 2011 ·Antimicrobial Agents and Chemotherapy ·Ranjith Rajendran, Eilidh Mowat, Elaine McCulloch, David F. Lappin, B Jones, Sue Lang, Jayesh B. Majithiya, Peter Warn, Craig Williams, Gordon Ramage	113
4	Peroral Amphotericin B Polymer Nanoparticles Lead to Comparable or Superior In Vivo Antifungal Activity to That of Intravenous Ambisome® or Fungizone™ 2011 ·PLoS ONE ·(unknown), Joanne Sharp, Katharine C. Carter, Peter Warn, M. N. V. Ravi Kumar	45
5	Pharmacokinetics and Pharmacodynamics of Posaconazole for Invasive Pulmonary Aspergillosis: Clinical Implications for Antifungal Therapy 2011 ·The Journal of Infectious Diseases ·Susan J. Howard, Jodi M. Lestner, Joanne Sharp, Lea Gregson, Joanne Goodwin, Joanne Slater, Jayesh B. Majithiya, Peter Warn, William Hope	81
6	Candida tropicalisin human disease 2010 ·Critical Reviews in Microbiology ·Louis Yi Ann Chai, David W. Denning, Peter Warn	103
7	Pathogenicity ofAspergillus fumigatusmutants assessed inGalleria mellonellamatches that in mice 2010 ·Medical Mycology ·Joanne Slater, Lea Gregson, David W. Denning, Peter Warn	115
8	In VitroAntifungal Activity of Isavuconazole against 345 Mucorales Isolates Collected at Study Centers in Eight Countries 2009 ·Journal of Chemotherapy ·Paul E. Verweij, Gloria M. González, Nathan P. Wiederhold, Cornelia Lass‐Flörl, Peter Warn, M. Heep, Mahmoud A. Ghannoum, Jesús Guinea	54
9	Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatus 2009 ·International Journal of Antimicrobial Agents ·Peter Warn, Joanne Sharp, Graham Morrissey, David W. Denning	31
10	Don’t throw your blood clots away: use of blood clot may improve sensitivity of PCR diagnosis in invasive aspergillosis 2009 ·Journal of Clinical Pathology ·Elaine McCulloch, Gordon Ramage, B Jones, Peter Warn, (unknown), (unknown), Craig Williams	27
11	In Vivo Efficacy of a New Antifungal Agent, FG3409 in a Murine Model of Disseminated Aspergillosis 2008 ·46th Annual Meeting ·Peter Warn	1
12	Efficacy of FG3409 a New Antifungal Agent, in Reducing Tissue Burden in Murine Models of Disseminated Aspergillosis 2008 ·46th Annual Meeting ·Peter Warn	2
13	Aspergillus flavus: human pathogen, allergen and mycotoxin producer breakdown → 2007 ·Microbiology ·Mohammad Taghi Hedayati, Alessandro C. Pasqualotto, Peter Warn, Paul Bowyer, David W. Denning	703
14	Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus 2006 ·Journal of Antimicrobial Chemotherapy ·Peter Warn, Joanne Sharp, Juan Alejandro Neira Mosquera, Jochen Spickermann, Anne Schmitt‐Hoffmann, M. Heep, David W. Denning	71
15	Surface Response Modeling to Examine the Combination of Amphotericin B Deoxycholate and 5‐Fluorocytosine for Treatment of Invasive Candidiasis 2005 ·The Journal of Infectious Diseases ·William Hope, Peter Warn, Joanne Sharp, Paul Reed, Brian Keevil, Arnold Louie, David W. Denning, George L. Drusano	16
16	In vitro activity of a new triazole BAL4815, the active component of BAL8557 (the water-soluble prodrug), against Aspergillus spp. 2005 ·Journal of Antimicrobial Chemotherapy ·Peter Warn, Joanne Sharp, David W. Denning	76
17	The epidemiology of hookworm infection and its contribution to anaemia among pre-school children on the Kenyan coast 1999 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·S Brooker, Norbert Peshu, Peter Warn, Moses Mosobo, Helen Guyatt, Kevin Marsh, Robert W. Snow	133
18	Receptor-Specific Adhesion and Clinical Disease in Plasmodium falciparum 1997 ·American Journal of Tropical Medicine and Hygiene ·Chris Newbold, Peter Warn, Gillian F. Black, Anthony R. Berendt, Alister Craig, Robert W. Snow, (unknown), Norbert Peshu, (unknown)	283
19	Serum tumour necrosis factor in children suffering from Plasmodium falciparum infection in Kilifi District, Kenya 1994 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·(unknown), Peter Warn, Charles R. Newton, (unknown), (unknown)	12
20	A single dose of intramuscular sulfadoxine-pyrimethamine as an adjunct to quinine in the treatment of severe malaria: pharmacokinetics and efficacy 1993 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·Charles R. Newton, P.A. Winstanley, W.M. Watkins, Isaiah Mwangi, C Waruiru, E.K. Mberu, Peter Warn, C.G. Nevill, Kevin Marsh	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact